Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016. [PDF]
, 2016 BACKGROUND: In 1976, the first cases of Ebola virus disease in northern Democratic Republic of the Congo (then referred to as Zaire) were reported. This article addresses who was responsible for recognizing the disease; recovering, identifying, and ...
Breman, Joel G +11 more
core +1 more source
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1
Advanced Science, Volume 12, Issue 48, December 29, 2025.This study identifies transmembrane protein adipocyte‐associated 1 (TPRA1) as a novel receptor for oncolytic virus M1 (OVM). TPRA1's ectodomain binds OVM particles, while its intracellular domain facilitates virus internalization, promoting efficient viral entry.
Linyi Hu +20 more
wiley +1 more source
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
Emerging Infectious Diseases, 2016 We report a case of probable Zaire Ebola virus–related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia.
John R. Chancellor +12 more
doaj +1 more source
Automatic Classification of the Movements of Directed and Undirected Subviral Particles
Current Directions in Biomedical Engineering, 2020 The development of drugs against pathogens that cause hemorrhagic fever, such as Marburg and Ebola virus, requires researchers to gather much information about the virus.
Kaak Michelle +2 more
doaj +1 more source
Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control [PDF]
, 2015 Ebola causes severe illness in humans and has epidemic potential. How to deploy vaccines most effectively is a central policy question since different strategies have implications for ideal vaccine profile. More than one vaccine may be needed.
Coltart, CE, Johnson, AM, Whitty, CJ
core +1 more source
Research progress Ebola Hemorrhagic Fever vaccine
Journal of Applied Virology, 2015 <p>Ebola hemorrhagic fever is a potent infectious disease by Ebola virus caused 90% mortality rate. Ebola virus was first isolated in 1976 by, for single-stranded negative segment, non-segmented, enveloped RNA viruses belonging to filamentous virus family. Ebola virus can be divided into five different subtypes.
Yunpeng Wang, Yuchen Zhang
openaire +1 more source
ChemistryOpen, Volume 14, Issue 12, December 2025.DrugBank database is mined to hunt prospective Ebola virus (EBOV) VP35 inhibitors utilizing docking calculations, molecular dynamics, molecular mechanics/generalized Born surface area binding energy calculations, and density functional theory computations.
Alaa H. M. Abdelrahman +5 more
wiley +1 more source
Post-Ebola Measles Outbreak in Lola, Guinea, January–June 2015
Emerging Infectious Diseases, 2016 During public health crises such as the recent outbreaks of Ebola virus disease in West Africa, breakdowns in public health systems can lead to epidemics of vaccine-preventable diseases. We report here on an outbreak of measles in the prefecture of Lola,
Jonathan E. Suk +14 more
doaj +1 more source
Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease
Emerging Infectious Diseases, 2014 Outbreaks of Ebola virus disease (EVD) occur sporadically in Africa and are associated with high case-fatality rates. Historically, children have been less affected than adults.
Anita K. McElroy +6 more
doaj +1 more source
The Boston University Photonics Center annual report 2014-2015 [PDF]
, 2015 This repository item contains an annual report that summarizes activities of the Boston University Photonics Center in the 2014-2015 academic year. The report provides quantitative and descriptive information regarding photonics programs in education ...
The Boston University Photonics Center
core